Tao Wang, Chengyong Wu, Chengdi Wang, Guiping Zhang, Kinsie Arnst, Yijun Yao, Zhixiong Zhang, Yuxi Wang, Dan Pu, Weimin Li, Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design. Biochemical and Biophysical Research Communications, 525, 148-154(2020).
https://doi.org/10.1016/j.bbrc.2019.12.083